Lilly launches higher dose vials of weight-loss drug for $150 less than injector pen
Eli Lilly said on Tuesday it has begun selling higher doses of its popular weight-loss drug Zepbound in vials in the U.S. at ...
The Latest: Musk Renews Threat to Fire Federal Workers Despite Pushback From Various Agencies
Elon Musk is vowing yet again to fire any federal workers who don’t respond to an email asking them to list five things they ...
manilatimes40m
Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products
Natalin and Acelagraft™ are the latest additions to Celularity's portfolio of HCT/P 361 products for use in the treatment of partial and full thickness acute and chronic wounds ...
manilatimes40m
BioRestorative to Provide a Positive FDA Update on Clinical Pipeline
BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) (NASDAQ: BRTX), a clinical stage regenerative ...
Hims & Hers shares drop on doubts over weight-loss business forecast
Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...
They were told to get extra breast cancer screenings. Then they got stuck with the bill.
Increasing numbers of women are getting additional screenings to rule out breast cancer. But such screenings cost money, out ...